Comment on "Dexamethasone-sparing on days 2-4 with combined palonosteron, neurokinin-1 receptor antagonist, and olanzapine in cisplatin: a randomized phase III trial (SPARED Trial)".

Authors :: Celio L
Antonuzzo A
Aapro MS
Source :: British journal of cancer [Br J Cancer] 2024 Apr; Vol. 130 (6), pp. 895-896. Date of Electronic Publication: 2024 Feb 26.
Publication Year :: 2024

Subjects :: Humans
Clinical Trials, Phase III as Topic
Dexamethasone
Olanzapine
Randomized Controlled Trials as Topic
Cisplatin
Neurokinin-1 Receptor Antagonists therapeutic use

Full Text Access

Tools